Skip to main content
Log in

Delayed warfarin induced skin necrosis in a patient with poor warfarin metabolizing activity due to interrupted warfarin therapy

  • Letter to the Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Nazarian RM, Van Cott EM, Zembowicz A, Duncan LM (2009) Warfarin-induced skin necrosis. J Am Acad Dermatol 61:325–332

    Article  PubMed  Google Scholar 

  2. DeFranzo AJ, Marasco P, Argenta LC (1995) Warfarin-induced necrosis of the skin. Ann Plast Surg 34:203–208

    Article  PubMed  CAS  Google Scholar 

  3. Esmerian MO, Mitri Z, Habbal MZ, Geryess E, Zaatari G, Alam S et al (2011) Influence of CYP2C9 and VKORC1 polymorphisms on warfarin and acenocoumarol in a sample of Lebanese people. J Clin Pharmacol 51:1418–1428

    Article  PubMed  CAS  Google Scholar 

  4. McGehee WG, Klotz TA, Epstein DJ, Rapaport SI (1984) Coumarin necrosis associated with hereditary protein C deficiency. Ann Intern Med 101:59–60

    PubMed  CAS  Google Scholar 

  5. Kurt M, Shorbagi A, Aksu S et al (2007) Warfarin-induced skin necrosis and leucocytoclastic vasculitis in a patientwith acquired protein C and protein S deficiency. Blood Coagul Fibrinolysis 18:805–806

    Article  PubMed  Google Scholar 

  6. Abdel-Wahab OI, Rosovsky RP, Warth JA (2008) Warfarin-induced skin necrosis in a patient with heparin-induced thrombocytopenia: two diseases or one? Acta Haematol 120:117–122

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shrimati Shetty.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gaikwad, T., Ghosh, K. & Shetty, S. Delayed warfarin induced skin necrosis in a patient with poor warfarin metabolizing activity due to interrupted warfarin therapy. Eur J Clin Pharmacol 69, 293–294 (2013). https://doi.org/10.1007/s00228-012-1332-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-012-1332-4

Keywords

Navigation